The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
about
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseasePredicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyClinical Practice Guideline: TinnitusEarly-onset Alzheimer's disease: nonamnestic subtypes and type 2 ADPharmacological interventions for apathy in Alzheimer's diseaseOmega-3 fatty acids for the treatment of dementiaMini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Statin withdrawal in people with dementiaRegional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementiaInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingOmega 3 fatty acids for the treatment of dementiaMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingIntravenous immunoglobulin for Alzheimer's diseaseSouvenaid for Alzheimer's diseaseInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settingsMini-Mental State Examination (MMSE) for the detection of Alzheimer’s dementia and other dementias in asymptomatic and previously clinically unevaluated people aged over 65 years in community and primary care populationsInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingAD-8 for diagnosis of dementia across a variety of healthcare settingsInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsMini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingNeuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesCholinesterase inhibitors for mild cognitive impairmentIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingPlasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingThe accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCIrCBF SPECT for detection of frontotemporal dementia in people with suspected dementiaMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingThe role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)Neuroeconomic dissociation of semantic dementia and behavioural variant frontotemporal dementiaAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
P2860
Q21146622-8CA2B71C-7A7F-4698-AC62-E7F1131AB97CQ21146623-1B737F07-3EC1-475A-8C2B-404BB37DB6DFQ22241833-1472527E-144B-42BE-99AC-C79401B8F71EQ22252525-967795BD-7631-4903-9D90-B2FC83DBBA82Q24185815-6CDB319C-3984-41DE-96BF-5B5237CA19BEQ24185910-B28034D1-967C-48F1-87DF-857276BC3ACBQ24186302-6057FB11-BAD5-481D-B0E7-7E4F1C7E944CQ24186399-02B9251D-70BD-42D6-B87A-433CE0A5FBBCQ24186720-B877E398-E0A9-480B-B655-44B75112687AQ24186916-AD7F536D-5AFE-4024-8EE5-53DE4C379AACQ24187059-6149F5C5-AB55-40C4-BFCF-B14227A9D362Q24187527-09AAC859-A007-4C62-A7AB-6F4801F9EF0DQ24187538-9253F7CC-0510-444B-BD1B-ECE85F8EA3CFQ24187713-2CC0BA7F-32B6-4129-8F2A-777C3A170F29Q24187908-7E4A4060-8786-418F-BF2A-E620C54F8E53Q24188215-7083F1FD-7DDB-4964-B282-E7CC0DC28BDDQ24188326-9AA9E04B-AC7D-49C6-959A-1FF3344D00FBQ24193211-B3285FBF-7BDA-48E6-B5B6-73EE47AD9090Q24194186-9C9AB1FC-4D3E-4FAE-8F44-36D39F5E7034Q24194747-7202CF5C-49CE-43ED-A7B8-AC4E799789DFQ24194796-A7802633-D82E-4E3F-9C9B-1C257CE96203Q24194962-4EAD6828-89E5-4AFB-86D3-B99FC2CBDAFCQ24197659-E23C51D5-430D-4832-9504-5B47426EA278Q24197665-418E9339-5BEC-42C0-96D5-DD1CBFC1B169Q24197672-D706CB24-B31E-4CED-BAD6-CF3E780D1900Q24200257-19C3B8B9-3B1E-43DD-B9B7-E23BF15E8C93Q24200430-19878518-7364-4364-A1F5-7EED81718946Q24200918-1D8AEA77-AD79-47C8-B5C7-BF5404772FF3Q24201260-10D8AAA2-637B-47D5-A1D4-CCA713C1398DQ24201265-479D235C-077B-4DE2-BCA0-47F09FA350CCQ24201271-808281BC-3271-487C-93BF-213623FD7F80Q24201276-EFA0E43D-21C5-491B-A77E-80A5BE0949ACQ24201440-2D7A5EB4-AD46-4A36-9B27-C92452E2EFD8Q24202037-17462DA8-FB9C-4226-BF72-EC3C1D9342CDQ24202610-94BA3095-BAC8-4090-9FEC-917247C47288Q24203748-0E9E5F06-A700-4C0B-B7E4-7A5470AD3513Q24289197-52BA1BF3-533D-4A18-86CF-0488CDD460FFQ24594531-38282E3F-BF7E-464A-90D4-D6BF2054E5A5Q24595802-62421064-B79D-43B3-B1E3-DFA13CEE1904Q24598142-1CB9EBEB-CAD2-4EC9-9F38-F417F5986CB2
P2860
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The diagnosis of dementia due ...... elines for Alzheimer's disease
@ast
The diagnosis of dementia due ...... elines for Alzheimer's disease
@en
type
label
The diagnosis of dementia due ...... elines for Alzheimer's disease
@ast
The diagnosis of dementia due ...... elines for Alzheimer's disease
@en
altLabel
The diagnosis of dementia due ...... elines for Alzheimer's disease
@en
prefLabel
The diagnosis of dementia due ...... elines for Alzheimer's disease
@ast
The diagnosis of dementia due ...... elines for Alzheimer's disease
@en
P2093
P2860
P50
P3181
P1476
The diagnosis of dementia due ...... elines for Alzheimer's disease
@en
P2093
Bill Thies
Bradley T Hyman
Claudia H Kawas
Creighton H Phelps
Guy M McKhann
Howard Chertkow
Jennifer J Manly
John C Morris
Maria C Carrillo
Philip Scheltens
P2860
P304
P3181
P356
10.1016/J.JALZ.2011.03.005
P407
P577
2011-04-21T00:00:00Z